Chlordiazepoxide

Chlordiazepoxide is an orally available benzodiazepine used for therapy of anxiety disorders and alcohol withdrawal syndromes. As with other benzodiazepines, chlordiazepoxide is not associated with serum aminotransferase or alkaline phosphatase elevations during therapy, and clinically apparent liver injury from chlordiazepoxide has been reported but is rare. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines, Psychotropic agents, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Methaminodiazepoxide, Chlozepid and Librelease. It is listed as a controlled drug substance (Schedule IV). Its PubChem SID is 505571326.